Indivior (INDV) Chief Accounting Officer Anderson Buys 1,500 Shares

What Happened
Woodrow D. Anderson, Chief Accounting Officer of Indivior Pharmaceuticals (INDV), acquired 1,500 shares in an open-market purchase on August 5, 2026. The shares were bought at $36.28 per share for a total transaction value of $54,420. This was a direct purchase of common stock (transaction code P), not an option exercise or award.

Key Details

• Transaction date: 2026-08-05
• Price: $36.28 per share; Total: $54,420
• Transaction type: Open-market purchase (code P)
• Shares owned after transaction: Not specified in the provided filing
• Footnotes/plan: Filing does not indicate a 10b5-1 plan, tax withholding, or other special footnotes
• Timeliness: Report filed on 2026-08-05 (same day), indicating a timely Form 4 filing

Context
This was a straightforward, non-derivative purchase by an executive. Purchases by company insiders can be of interest to investors, but they do not guarantee future stock performance. The Form 4 shows an acquisition only; there is no indication shares were sold or that this was part of a planned exercise or award.